Projects per year
Personal profile
Research expertise
Tinne Gils (1985°) graduated as a pharmacist (Catholic University of Leuven, 2008) and obtained a postgraduate in Tropical Biomedical Sciences (Institute for Tropical Medicine (ITM), 2010) and a Master's in International Humanitarian Action (University Paul Cézanne, Aix-en-Provence, 2012).
Between 2011 and 2018, she worked as an HIV/TB pharmacist with Doctors Without Borders (MSF) across Africa (mainly in South Africa, Lesotho, and Mozambique), focusing on access to medicines.
She obtained a Master of Public Health (epidemiology and biostatistics, University of Cape Town, 2019) and worked with MSF in Ukraine as an epidemiologist on tuberculosis.
In 2020, she joined the Unit of HIV & TB at ITM, where her focus has been on advanced HIV disease, drug-resistant tuberculosis, and academic writing. She started a PhD in 2022.
Education/Academic qualification
Master of Public Health, epidemiology and biostatistics, University of Cape Town
Award Date: 12-Dec-2019
Master in International Humanitarian Action, Aix-Marseille Université
Award Date: 27-Sept-2012
Postgraduate in Tropical Biomedical Sciences & International Health, Institute of Tropical Medicine
Award Date: 8-Mar-2010
Master in Pharmaceutical Sciences, KU Leuven
Award Date: 7-Jul-2008
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Finished
-
Implementation and outcomes of the advanced HIV care package in high HIV/TB burden settings
Gils, T., Lynen, L., Decroo, T., Vlieghe, E. & Reither, K.
8/06/23 → 30/06/25
Project: PhD-project
Research output
-
Effectiveness and cost-effectiveness of community-based TB screening algorithms using computer-aided detection (CAD) technology alone compared with CAD combined with point-of-care C reactive protein testing in Lesotho and South Africa: protocol for a paired screen-positive trial: protocol for a paired screen-positive trial
Signorell, A., van Heerden, A., Ayakaka, I., Jacobs, BK., Antillon, M., Tediosi, F., Verjans, A., Brugger, C., Harkare, HV., Labhardt, ND., Bosman, S., Kamele, M., Keitseng, M., Madonsela, T., Kurscheid, J., Muhairwe, J., Keter, AK., Murphy, K., van Ginneken, B., Gils, T., & 8 others, 2025, In: BMJ Open. 15, 7, 14 p., e093989.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
"If your CD4 count lowers, that is when you are similar to a person that is non-existent" A qualitative exploration of perceptions around advanced HIV disease in South Africa
Pita, TP., Misra, S., Madonsela, T., Tshazi, A., Bosman, S., Ayakaka, I., Vlieghe, E., Decroo, T., Reither, K., van Heerden, A. & Gils, T., 2025, In: BMC Public Health. 25, 13 p., 2325.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Implementation and outcomes of the advanced HIV disease care package in high HIV/TB burden settings
Gils, T., 30-Jun-2025, Antwerpen: Universiteit Antwerpen. 289 p.Research output: Thesis › Doctoral dissertation - Doctoral dissertation › peer-review
-
Optimal dosing and duration of linezolid for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis: an individual patient data meta-analysis
Kwak, N., Kim, JY., Han, AR., Berry, C., Beumont, M., Tweed, C., Crook, A., Dheda, K., Fabiane, S., Fadeyi, MO., Foraida, S., Gils, T., Hoang, TTT., Jham, MA., Murphy, RA., Nguyen, BH., Nguyen, TMP., Nyang'wa, BT., Oelofse, S., Hahn, S., & 1 others, 2025, In: European Respiratory Journal. 66, 2, 10 p., 2500315.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Pretreatment attrition after rifampicin-resistant tuberculosis diagnosis with Xpert MTB/RIF or ultra in high TB burden countries: a systematic review and meta-analysis
Jouego, CG., Decroo, T., Netongo, PM. & Gils, T., 2025, In: BMJ Global Health. 10, 1, 7 p., e015977.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access